PHR logo

PHREESIA INC

PHRNYSE
πŸ† #2559 by market capEarnings Dec 7US Equity
$12.35β–Ό $0.02 (βˆ’0.16%)
Latest quote
πŸ””
Track PHR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.2%
7dβ–Ό 2.9%
14dβ–² 11.9%
30dβ–² 23.3%
ytdβ–Ό 27.0%
1yβ–Ό 46.8%
🏦Market Cap
$767M
Small Cap
πŸ“ˆRevenue Growth (YoY)
12.9%
Healthy
πŸ“ŠGross Margin
67.5%
High
πŸ’΅FCF Margin
13.3%
Healthy
βš–οΈP/S Ratio
1.5x
Cheap
Otter Score
84
Strong

Trading Snapshot

Day Range
$12.21 – $12.47
52-Week Range
$7.77 – $23.87
Volume (shares)
28,022
Avg Volume (shares)
β€”
Shares Outstanding
62.1M
Next Earnings
2026-12-07

Fundamentals Snapshot

Annual Revenue
$481M
Last Q Revenue
$129M
P/E Ratio
73.6
P/S Ratio
1.5x
EPS (TTM)
$0.17
Dividend Yield
β€”
Dilution (1yr)
+1.6%
PHR logo

PHREESIA INC

PHR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$481Mβ–² +14.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
67.9%β–² +0.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$7Mβ–Ό βˆ’88.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$68Mβ–² +716.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
62.5Mβ–² +1.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5Mβ–Ό βˆ’$91M YoY
StockOtter Β· stockotter.space

About PHREESIA INC

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
84/100

Analyst Ratings

β“˜
Consensus
Buy
22 analysts
Strong Buy3
Buy10
Hold9
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

Defense WorldΒ·11d ago

Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)

National Research (NASDAQ: NRC - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the st

Business WireΒ·21d ago

Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Michael Rasbury, VP of AccessOne Solutions, named to Becker's Hospital Review's 2026 Rising Stars: Healthcare Leaders Under 40 list.

Business WireΒ·29d ago

Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME's list of the World's Top HealthTech Companies of 2026. This marks the second co

Defense WorldΒ·Sep 23

Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock

Phreesia, Inc. (NYSE: PHR - Get Free Report) General Counsel Allison Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total val

Business WireΒ·Sep 14

Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace.

The Motley FoolΒ·Sep 8

Why Phreesia Stock Got Knocked Down Today

This added to lingering negative sentiment following the company's latest earnings release. Investors didn't like the fact that it whiffed on earnings.